TOR-103

N/A

Report date: 2024/12/05 13:56:34
NME

Base Information

Drug NameTOR-103
Drug Alias NameTOR-103TOR103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasmsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCambrian Biopharma IncTornado therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCambrian Biopharma IncTornado therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasmsRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A